MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Identification of potential new genes involved in autosomal recessive forms of Parkinson’s disease

    C. Tesson, A. Honoré, V. Drouet, H. Bertrand, S. Lesage, A. Brice (Paris, France)

    Objective: The aim of the work is to identify new genes involved in autosomal recessive (AR) early-onset (EO, >40 years) Parkinson disease (PD), using consanguineous…
  • 2019 International Congress

    Lip movement contribution in speech production of persons with Parkinson’s Disease

    P. Upadhyay, S. Gudwani, K. Sharma, R. Sagar, R. Dhamija, S. Kumaran (New Delhi, India)

    Objective: Lip movements contribute to communication by producing labial sounds, conveying facial expression and aiding visually in speech perception. This study planned to understand lip-movements…
  • 2019 International Congress

    The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Healthcare Resource Utilization (HCRU)

    T. Xie, X. Ye, J. de Courcy, J. Mellor, J. Zamudio, L. Chiodo, Y. Bao (Mettawa, IL, USA)

    Objective: To measure the impact of PSP disease severity on HCRU in a real-world setting. Background: PSP is a neurodegenerative disease. As it progresses, patients’…
  • 2019 International Congress

    The Chinese Parkinson’s disease Registry scheme

    XT. Zhou, XX. Zhou, YW. Zhao, LX. Qin, Q. Xu, Y. Tian, LJ. Fang, ZQ. Wang, QY. Sun, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: This large prospective longitudinal cohort aims to identify nature history of a highly-presentative Chinese PD population and to discern clinical and genetic markers which…
  • 2019 International Congress

    Motor-based assessment of prodromal Parkinson’s disease combining wearable sensors and machine learning

    E. Rovini, A. Moschetti, L. Fiorini, D. Esposito, C. Maremmani, F. Cavallo (Pontedera, Italy)

    Objective: To provide the neurologist with a decision support system based on inertial sensors and learning algorithms for an objective early diagnosis of Parkinson’s disease…
  • 2019 International Congress

    Validation of the Hebrew version of the Unified Dyskinesia Rating Scale (UDysRS)

    A. Socher, A. Thaler, H. Shabtai, J. Zitser, T. Shainer, M. Kestenbaum, A. Rosenberg, A. Bar David, A. Ezra, T. Taichman, M. Brozgol, T. Herman, G. Stebbins, C. Goetz, S. Luo, P. Martinez-Martin, N. Giladi, T. Gurevich (Mdrid, Spain)

    Objective: To assess the clinimetric properties of the Hebrew version of the UDysRS. Background: Dyskinesia is a common side effect of dopaminergic treatments for Parkinson's…
  • 2019 International Congress

    Impaired intracortical inhibition predicts response to medication in Parkinson’s disease patients

    SR. Filipović, A. Kačar, S. Milanović, M. Ljubisavljević, VS. Kostić (Beograd, Serbia)

    Objective: To check whether measures of motor cortex excitability and plasticity are associated with clinical response to dopaminergic treatment in Parkinson’s disease (PD) patients. Background:…
  • 2019 International Congress

    Characterising the role of alpha-synuclein in ferroptotic programmed cell death in the context of Parkinson’s Disease

    L. Mahoney-Sánchez, H. Bouchaoui, K. Timmerman, A. Jonneaux, S. Ayton, J. Duce, JC. Devedjian, D. Devos (Lille, France)

    Objective: Despite the involvement of alpha synuclein (α-syn) pathology in Parkinson's disease (PD) pathology, the consequences on the neuropathology and the type of programmed cell…
  • 2019 International Congress

    Comparison of LFP-physiomarkers for DBS programming

    G. Wenzel, S. Ewert, A. Horn, B. van Wijk, A. Kühn (Berlin, Germany)

    Objective: To evaluate clinical usability of LFP(local field potentials)-physiomarkers and lead localisation for selection of suitable DBS electrode configurations. Background: Selection of optimal contacts in…
  • 2019 International Congress

    Touching Nose: Alleviating Maneuvers (Sensory Tricks) in Orofacial Dystonia

    NG. Bülbül, MG. şenol (Istanbul, Turkey)

    Objective: Orofacial dystony is a type of focal dystonia that affects the facial and masticatory, cervical, laryngeal, eyelid, and pharyngeal muscles. Background: We present a…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley